EUVIMEDEUVIMED entdecken
Open Access

Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases

Benjamin E Deprez, Debayan Dey, Natalia Zelinskaya, Erika E Csatary, Qimin Winnie Yang, Minhua Nie, Graeme L Conn iD, William M Wuest iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Benjamin E Deprez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Emory University, Atlanta, Georgia, 30322, USA. Hauptthemen laut MEDLINE: Methyltransferases, Aminoglycosides, Drug Design, Enzyme Inhibitors. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the major mechanisms of resistance to ribosome‐targeting antibiotics is the modification of ribosomal RNA (rRNA). Specific methyltransferase enzymes, for example, confer high‐level resistance to aminoglycosides by selectively methylating the 16S rRNA in the ribosomal decoding center. These enzymes have been detected globally and pose a threat to the continued use of aminoglycosides. Compound 1 , a dehydroamino amide inhibitor of the m 1 A1408 methyltransferase NpmA, was previously disclosed and identified using high‐throughput virtual screening. Here, the synthesis and biological evaluation of rationally designed analogs of 1 has been reported. Guided by molecular docking, additional putative inhibitors of NpmA, as well as the functionally related m 7 G1405 methyltransferase RmtB, varying in each region of the original scaffold are disclosed. A modular, fragment‐based synthesis enables access to 17 analogs, which exhibits mixed activity against NpmA and RmtB, including several that are selective for RmtB. The structure–activity relationship determined for the dehydroamino amide series will guide continued research against this target class with the aim of developing a toolkit for selective‐ or pan‐16S rRNA methyltransferase inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesAminoglycosidesDrug DesignEnzyme InhibitorsAnti-Bacterial AgentsRNA, Ribosomal, 16SStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureDrug Resistance, BacterialMicrobial Sensitivity TestsEscherichia coliDose-Response Relationship, DrugEscherichia coli Proteins

Stichwörter der Autor:innen

aminoglycosidesantibioticsmolecular modeling molecular dynamicsstructure–activity relationships

Substanzen

MethyltransferasesAminoglycosidesEnzyme InhibitorsAnti-Bacterial AgentsRNA, Ribosomal, 16SNpmA protein, E coliEscherichia coli Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Emory University, Atlanta, Georgia, 30322, USA.
  • Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, 30322, USA.

ORCID-Profile: Graeme L Conn, William M Wuest

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIAID
  • NIGMS
  • NIDDK

Zitieren

APA

Deprez, B. E., Dey, D., Zelinskaya, N., Csatary, E. E., Yang, Q. W., Nie, M., Conn, G. L., & Wuest, W. M. (2026). Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases. ChemMedChem. https://doi.org/10.1002/cmdc.202500889

Vancouver

Deprez BE, Dey D, Zelinskaya N, Csatary EE, Yang QW, Nie M, et al. Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases. ChemMedChem. 2026. doi:10.1002/cmdc.202500889

BibTeX
@article{Deprez2026,
  author = {Deprez, Benjamin E and Dey, Debayan and Zelinskaya, Natalia and Csatary, Erika E and Yang, Qimin Winnie and Nie, Minhua and Conn, Graeme L and Wuest, William M},
  title = {Design, Synthesis, and Evaluation of Novel Inhibitors of Aminoglycoside‐Resistance 16S Ribosomal RNA Methyltransferases},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500889}
}
Kostenlos starten →